Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Gold Price Monitor -- Ignore unavailable to you. Want to Upgrade?

To: goldsheet who wrote (66830)	4/1/2001 1:54:36 AM
From: long-gone	Read Replies (1) \| Respond to of 116759

<<2000-dated American Eagles>> Gold silver or a mix of both?

To: goldsheet who wrote (66830)	4/3/2001 8:18:18 AM
From: long-gone	Read Replies (1) \| Respond to of 116759

So, then I guess Bankers are just far more morally right & upstanding than Drug Companies. There can be collusion between drug companies to keep prices higher but, no, never would bankers collude to keep precious metals prices low. April 3, 2001 F.T.C. Accuses Drug Makers Of Collusion to Delay Generics By BLOOMBERG NEWS ASHINGTON, April 2 — The Federal Trade Commission accused the Schering- Plough Corporation today of paying $90 million to the American Home American Home Products Corporation and another company to delay sales of a low-cost generic drug taken by heart patients. The F.T.C. also said that Aventis and the Andrx Corporation had settled charges that Aventis had paid Andrx $90 million to delay release of a generic version of Cardizem CD, Aventis's popular heart medicine. The F.T.C. said Schering-Plough colluded with American Home Products and Upsher-Smith Laboratories to delay sales of alternatives to Schering's K-Dur 20 potassium-chloride supplement. The administrative (cont) nytimes.com